What is it about?
This meeting report examines recent advancements in cancer immunity and immunotherapy within the post-COVID-19 landscape. Key highlights include progress in cancer vaccines and checkpoint blockade agents, as well as emerging adoptive immunotherapy strategies.
Featured Image
Photo by National Institute of Allergy and Infectious Diseases on Unsplash
Read the Original
This page is a summary of: Cancer immunity and immunotherapy beyond COVID-19, Medical Oncology, March 2023, Springer Science + Business Media,
DOI: 10.1007/s00262-023-03411-9.
You can read the full text:
Resources
Contributors
The following have contributed to this page
